Botswana Smoking and Abstinence Reinforcement Trial

• Status: Not yet recruiting
• Trial end date: 2027-08-31
• Target enrollment: 0
• Participant gender: All

Summary

Many people living with HIV in southern Africa, specifically Botswana use tobacco products. Using tobacco makes some of the effects of HIV worse and even causes excess deaths. The investigators plan to use an intervention called Screening, Brief Intervention and Referral to Treatment (SBIRT) to help people to quit smoking and also a drug called varenicline. Apart from helping people to stop smoking, the investigators will also test to see how task shifting can be used to help people stop smoking in a sustainable way. Finally, the investigators will estimate the cost of the intervention.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Maryland, Baltimore
• Collaborators: University of Kentucky; University of Maryland, Baltimore County; University of Maryland, College Park
• Treatments: Varenicline

Criteria

Inclusion Criteria:

• HIV infected

• Self reported current daily smoker

• Age 18 and older

• Engaged in HIV care as defined by being on ART for at least 6 months

• Willing/able to provide informed consent in English or Setswana

Exclusion Criteria:

• Less than 18 years of age

• Pregnant

• Unable or cognitively impaired to provide consent